Skip to main content
Figure 2 | BMC Health Services Research

Figure 2

From: A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

Figure 2

Lifetime costs and quality adjusted life years of treatment. (A) The lifetime costs and (B) Quality adjusted life years of treatment options of severe thalassemia classified by patient age at the start of treatments. THB: Thai baht (in 2008 value); BT-ICT: blood transfusion combined with subcutaneous iron chelating therapy; and HSCT: hematopoietic stem cell transplantation.

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us